Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,100 | 7,804 | 4,841 | 6,996 | 9,935 |
| Receivables | 706 | 513 | 1,642 | 1,445 | 1,215 |
| TOTAL | $8,134 | $8,782 | $6,765 | $8,826 | $11,580 |
| Non-Current Assets | |||||
| PPE Net | 93 | 106 | 107 | 127 | 153 |
| Other Non-Current Assets | 1,485 | 1,558 | 1,633 | 1,706 | 1,723 |
| TOTAL | $1,578 | $1,664 | $1,740 | $1,833 | $1,876 |
| Total Assets | $9,712 | $10,446 | $8,505 | $10,659 | $13,456 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,876 | 1,194 | 1,514 | 1,622 | 2,127 |
| TOTAL | $2,210 | $1,520 | $1,831 | $1,931 | $2,428 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,171 | 1,257 | 1,341 | 1,424 | 1,505 |
| TOTAL | $1,171 | $1,257 | $1,341 | $1,424 | $1,505 |
| Total Liabilities | $3,381 | $2,777 | $3,172 | $3,355 | $3,933 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,786 | 13,784 | 10,259 | 10,174 | 10,174 |
| Common Shares | 13 | 13 | 10 | 10 | 10 |
| Retained earnings | -342,249 | -339,823 | -337,774 | -335,719 | -333,418 |
| TOTAL | $6,331 | $7,669 | $5,333 | $7,304 | $9,523 |
| Total Liabilities And Equity | $9,712 | $10,446 | $8,505 | $10,659 | $13,456 |